Beyond the skin: The autoimmune burden of atopic dermatitis
Our study, published in The Journal of Allergy and Clinical Immunology (JACI), set out to close a gap in dermatological care.
The Clinical Gap: While atopic dermatitis (AD) has long been linked to allergies, it was previously unknown if the condition or its severity increases a patient's risk of developing other autoimmune diseases.
The Outcome: Using real-world primary care data from the Oxford-Royal College of General Practitioners Research and Surveillance Centre (RCGP RSC), this study revealed that AD is more than skin-deep. Patients face a higher chance of developing other immune system diseases, especially when their skin condition is more severe.
The Impact: These findings were rapidly integrated into official medical policy, serving as a key evidence source in the 2023 German S3-Guideline for Atopic Dermatitis and earning a feature in the prestigious JACI Editor's Choice section.
We've summarised the key takeaway message below.
To bring this study to life and uncover the autoimmune risks associated with atopic dermatitis, Momentum Data provided end-to-end project support.
The findings were so critical that they were rapidly integrated into official, government-recognised medical guidelines within just two years of publication.
They now serve as a key evidence source in the 2023 German S3-Guideline for Atopic Dermatitis to inform clinical policy.
Our core contributions included:
Study Conception: Project conceptualisation and methodology
Data Analysis: Comprehensive large-scale analysis of real-world data
Data Visualisation: Clear presentation of complex clinical findings
Medical Writing: Complete manuscript development
Publication Support: Targeted submission and review follow-up
Turning real world data into impactful evidence
Ultimately, our goal is simple:
To produce dynamic, engaging outputs that truly tell the story of the evidence - and make sure it’s heard.